In Brief: Oncor
This article was originally published in The Gray Sheet
Executive Summary
Oncor: Firm appoints Jose Coronas chairman of the board, effective immediately. Coronas, who served as president of Johnson & Johnson Clinical Diagnostics between 1994 and 1996, replaces Stephen Turner, who retains the title of CEO. Coronas joined J&J when it purchased Kodak's Clinical Diagnostics division. He has held a number of management positions at Kodak over a 28-year stint with the company. Coronas has served on the Oncor board and worked as an independent consultant for the past year...